Flu B or not Flu B: An atypical case of minimal change disease triggered by Influenza B presenting with multi-organ dysfunction

Flu B or not Flu B: An atypical case of minimal change disease triggered by Influenza B presenting with multi-organ dysfunction

Jordana Cheta1, Alamgir Mirza1, Michael Binder1, Sandeep Magoon1 and Thomas McCune1

1Affiliated with Eastern Virginia Medical School (EVMS), 825 Fairfax Avenue, Norfolk, Virginia 23507

International-Journal-of-Case-Reports-2d codeMinimal change disease (MCD) accounts for 10-15% of idiopathic nephrotic syndrome in adults. Patients typically present with nephrotic range proteinuria, hypertension, microscopic hematuria and can even progress to acute renal failure. MCD can be primary (idiopathic) or secondary from etiologies such as cancer, medications, autoimmune conditions and infections. The link between infectious etiologies for MCD is important to recognize, since MCD tends to show a good response to treatment of the underlying cause. Influenza A has been reported as a secondary cause of MCD and rarely, influenza A, not B, can also present with liver failure. We present an atypical case of a 60-year-old female with no past medical history who presented with liver failure along with acute kidney injury and nephrotic range proteinuria. She was diagnosed with liver failure and secondary MCD from influenza B, the first reported case, and made a full recovery with treatment of Influenza B.

Free Full-text PDF

How to cite this article:
Jordana Cheta, Alamgir Mirza, Michael Binder, Sandeep Magoon and Thomas McCune. Flu B or not Flu B: An atypical case of minimal change disease triggered by Influenza B presenting with multi-organ dysfunction. International Journal of Case Reports, 2018 2:20. DOI: 10.28933/ijcr-2018-05-1001.

1. Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D’Agati V, Appel G. Adult minimal-change disease: Clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol 2: 445–453, 2007 http://cjasn.asnjournals.org/content/2/3/445.full#ref-list-1
2. Vivarella M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol 12: 332-345, 2017 http://cjasn.asnjournals.org/content/12/2/332.full#ref-list-1
3. Hogan J, Radhakrishnan J. The treatment of minimal change disease in adults. J Am Soc Nephrol 24: 702-711, 2013 http://jasn.asnjournals.org/content/24/5/702.full
4. Glassock RJ. Secondary minimal change disease. Nephrol Dial Transplant 18[Suppl 6]: vi52–vi58, 2003 https://www.researchgate.net/publication/10585142_Secondary_minimal_change_disease
5. Krane NK, Espemnan P, Walker PD et al. Renal disease and syphilis. A report of nephrotic syndrome with minimal change disease. Am J Kidney Dis 1987; 9: 176–179 https://www.ncbi.nlm.nih.gov/pubmed/3826066
6. Scaglia F, Vogler LB, Hymes LC et al. Minimal change disease nephrotic syndrome: a possible complication of ehrlichiosis. Pediatr Nephrol 1999; 13: 600–601 https://link.springer.com/article/10.1007/s004670050666
7. Biox E, Rivera F, Gil CM et al. Steroid-responsive nephrotic syndrome with minimal change disease and IgA deposits in a HIV-infected patient. Nephrol Dial Transplant 2000; 15: 412–414 https://academic.oup.com/ndt/article/15/3/412/1805272?searchresult=1
8. Rathi AK, Kapoor AK. Tuberculosis and minimal change nephrotic syndrome in Lucknow, India. Trop Geogr Med 1980; 32: 227–230 https://www.ncbi.nlm.nih.gov/pubmed/7210157
9. Said MH, Layani MP, Colon S et al. Mycoplasma pneumonitis associated nephritis in children. Pediatr Nephrol 1999; 13: 39–44 https://www.ncbi.nlm.nih.gov/pubmed/10100287
10. Gelman R, Brook G, Green J et al. Minimal change glomerulonephritis associated with hydatid disease. Clin Nephrol 2000; 53: 152–155 http://europepmc.org/abstract/med/10711418
11. Kim SR, Lee SB, Kim IY, Lee DW, Rhee H, Seong EY, Song SH, Kwak IS. Relapse of minimal change disease following infection with the 2009 pandemic influenza (H1N1) virus. Clin Exp Nephrol 2012; 16: 329-332 https://www.ncbi.nlm.nih.gov/pubmed/22116504
12. Kwiatkowska E, Gołembiewska E, Ciechanowski K and Kędzierska K. Minimal-Change Disease Secondary to Borrelia Burgdorferi Infection. Case Reports in Nephrology 2012; 3 pages https://www.hindawi.com/journals/crin/2012/294532/
13. Clajus C, Spiegel J, Brocker V, Chatzikyrkou C, Kielstein J. Minimal change nephrotic syndrome in an 82-year-old patient following a tetanus-diptheria-poliomyelitis vaccination. BMC Nephrology 2009; 10: 21 https://bmcnephrol.biomedcentral.com/articles/10.1186/1471-2369-10-21
14. Kielstein JT, Termuhlen L, Sohn J, Kliem V. Minimal change nephrotic syndrome in a 65-year-old patient following influenza vaccination. Clin Nephrol 2000; 54: 246-248 https://www.ncbi.nlm.nih.gov/pubmed/11020024
15. Shimada M, Araya C, Rivard C, Ishimoto T, Johnson RJ, Garin EH. Minimal change disease: a “two-hit” podocyte immune disorder? Pediatric Nephrology 26: 645-649, 2010 https://www.ncbi.nlm.nih.gov/pubmed/21052729?dopt=Abstract
16. Kim SH, Park SJ, Han KH, et al. Pathogenesis of minimal change nephrotic syndrome: an immunological concept. Korean Journal of Pediatrics. 2016; 59(5): 205-211 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897155/#B8
17. Ravani P, Rossi R, Bonanni A, Quinn RR, Sica F, Bodria M, et al. Rituximab in children with steroid-dependent nephrotic syndrome: a multicenter, open-label, noninferiority, randomized controlled trial. J Am Soc Nephrol. 2015; 26:2259–2266 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552120/
18. Duchini A, Viernes ME, Nyberg LM, Hendry RM, Pockros PJ. Hepatic Decompensation in Patients with Cirrhosis During Infection With Influenza A. Arch Intern Med. 2000; 160(1):113–115. https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/485192?redirect=true&redirect=true
19. Papic N, Pangercic A, Vargovic M, Barsic B, Vince A, Kuzman I. Liver involvement during influenza infection: perspective on the 2009 influenza pandemic. Influenza and Other Respiratory Viruses. 2012; 6(3): e2-e5.
20. Shimizu Y. Liver in systemic disease. World Journal of Gastroenterology : WJG. 2008;14(26):4111-4119. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725369/
21. Adams DH, Hubscher SG. Systemic Viral Infections and Collateral Damage in the Liver. The American Journal of Pathology. 2006; 168(4): 1057-1059. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1606546/
22. Polakos NK, Cornejo JC, Murray DA, et al. Kupffer Cell-Dependent Hepatitis Occurs during Influenza Infection. The American Journal of Pathology. 2006; 168(4): 1169-1178. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1606556/
23. Whitworth, JR, Mack CL, O’Connor JA, Narkewicz MR, et al. Acute Hepatitis and Liver Failure Associated with Influenza A Infection in Children. J. Pediatric Gastroenterology and Nutrition. 2006; 43(4): 536-538. https://insights.ovid.com/pubmed?pmid=17033532#
24. Ellison RT, Horsburgh CR, Curd J. Complement levels in patients with hepatic dysfunction. Dig. Dis. Sci. 1990; 35(2): 231-5. https://www.ncbi.nlm.nih.gov/pubmed/2302981
25. Unsworth DJ. Complement deficiency and disease. J. Clin. Pathol. 2008; 61(9): 1013-7. https://www.ncbi.nlm.nih.gov/pubmed/18495794